NASDAQ:HCM

Hutchison China Meditech Adr (sponsored) Stock Insider Trading

etoro logo Buy HCM
*Your capital is at risk
$11.13
+0.360 (+3.34%)
At Close: Jul 31, 2026

Hutchison China Meditech ADR (Sponsored) Stock Insider Power

Based on the 52 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.06M and sold 0 HCM shares in the last 52 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 52 transactions)
100.00
Buy 3.06M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation
Buy Signal High Confidence
Jun 09, 2025

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 100.
  • Confidence increased due to high data reliability score of 90.
  • Supported by overwhelming buy-side pressure (100% buys).

Historical Insider Trades

Date Type Person Role Amount
Mar 10, 2026
Buy
ordinary shares
Eldar Dan
Director
Director 0
Value: $0
Mar 10, 2026
Buy
American depositary shares
Eldar Dan
Director
Director 0
Value: $0
Mar 10, 2026
Buy
Common Stock
J-Other
Wong Tak Wai
Director 0
Value: $0
Mar 10, 2026
Buy
American depositary shares
Mok Tony Shu Kam
Director
Director 0
Value: $0
Mar 10, 2026
Buy
ordinary shares
Bhatia Renu
Director
Director 0
Value: $0
Mar 10, 2026
Buy
Common Stock
J-Other
Tan Daniel Shao Weng
Director 0
Value: $0
Mar 10, 2026
Buy
Common Stock
J-Other
Yang Ling
Director 0
Value: $0
Jun 09, 2025
Buy
Share option (right to buy)
Su Wei-guo
CEO And Cso
CEO / President 1 493 435
Value: $23.8M
Jun 05, 2023
Buy
Share option (right to buy)
Nixon Charles George Rupert
Group General Counsel
Officer 4 520
Value: $56.5K
Jun 05, 2023
Buy
Share option (right to buy)
Chiu Lorenso
Deputy Chief Financial Officer
C-Suite Officer 3 000
Value: $37.5K
Jun 05, 2023
Buy
Share option (right to buy)
Cheng Chig Fung
Chief Financial Officer
C-Suite Officer 12 340
Value: $154.4K
May 23, 2022
Buy
Share option (right to buy)
Nixon Charles George Rupert
Group General Counsel
Officer 7 015
Value: $75.4K
May 23, 2022
Buy
Share option (right to buy)
Chiu Lorenso
Deputy Chief Financial Officer
C-Suite Officer 16 400
Value: $176.3K
May 23, 2022
Buy
Share option (right to buy)
Cheng Chig Fung
Chief Financial Officer
C-Suite Officer 89 320
Value: $960.2K
Dec 14, 2021
Buy
Share option (right to buy)
Nixon Charles George Rupert
Group General Counsel
Officer 4 087
Value: $143.9K
Dec 14, 2021
Buy
Share option (right to buy)
Su Wei-guo
CEO And Cso
CEO / President 4 986
Value: $175.6K
Mar 26, 2021
Buy
Share option (right to buy)
Nixon Charles George Rupert
Group General Counsel
Officer 31 620
Value: $883.5K
Mar 26, 2021
Buy
Share option (right to buy)
Chiu Lorenso
Deputy Chief Financial Officer
C-Suite Officer 7 120
Value: $198.9K
Mar 26, 2021
Buy
Share option (right to buy)
Su Wei-guo
CEO And Cso
CEO / President 56 480
Value: $1.58M
Mar 26, 2021
Buy
Share option (right to buy)
Cheng Chig Fung
Chief Financial Officer
C-Suite Officer 48 100
Value: $1.34M
Dec 14, 2020
Buy
Share option (right to buy)
Nixon Charles George Rupert
Group General Counsel
Officer 3 395
Value: $98.5K
Dec 14, 2020
Buy
Share option (right to buy)
Su Wei-guo
CEO And Cso
CEO / President 3 792
Value: $110.0K
Apr 28, 2020
Buy
Share option (right to buy)
Nixon Charles George Rupert
Group General Counsel
Officer 57 720
Value: $1.28M
Apr 28, 2020
Buy
Share option (right to buy)
Chiu Lorenso
Deputy Chief Financial Officer
C-Suite Officer 17 700
Value: $391.0K
Apr 28, 2020
Buy
Share option (right to buy)
Su Wei-guo
CEO And Cso
CEO / President 157 940
Value: $3.49M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT HUTCHISON CHINA MEDITECH LTD ADR (SPONSORED)
Hutchison China Meditech ADR (Sponsored)
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE